Characteristics of Climbers with High Altitude Pulmonary Edema on Mount Aconcagua
This study examined climbers who developed HAPE on Mount Aconcagua, yielding implications for high altitude illness prevention efforts and further study. HAPE cases were associated with insufficient nights at the 4300-m base camp and unresolved acute mountain sickness symptoms. The relationship between acetazolamide and HAPE warrants further study on Aconcagua.
Authors
- Sameer Sethi
- Aaron Brillhart
- R. Duplessis
- Sarah Schlein (ORCID: https://orcid.org/0000-0003-4983-763X)
- Andrew Park (ORCID: https://orcid.org/0000-0002-7511-2221)
- Bernabé Abramor
- Roxana Pronce
- Javier Seufferheld
Institutions
- University of Vermont (US)
Publication Details
- Journal
- Wilderness and Environmental Medicine
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1177/10806032241303438
- Citations
- 5
- Primary Topic
- High Altitude and Hypoxia
- Type
- article
- Field-Weighted Citation Impact
- 2.75
Funders
- University of Vermont